Late Breaking Abstract - Experimental Respiratory Syncytial Virus infection in adults 60-75 years

A. Mann (London, United Kingdom), M. Kalinova (London, United Kingdom), A. Catchpole (London, United Kingdom), O. Rusyn (London, United Kingdom), V. Horvathova (London, United Kingdom), K. Eze (London, United Kingdom), M. De Sa (London, United Kingdom), A. Bell (London, United Kingdom)

Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Session: Airway infection: the microbiome and beyond
Session type: Oral Presentation
Number: 4928
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Mann (London, United Kingdom), M. Kalinova (London, United Kingdom), A. Catchpole (London, United Kingdom), O. Rusyn (London, United Kingdom), V. Horvathova (London, United Kingdom), K. Eze (London, United Kingdom), M. De Sa (London, United Kingdom), A. Bell (London, United Kingdom). Late Breaking Abstract - Experimental Respiratory Syncytial Virus infection in adults 60-75 years. 4928

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Lung function before and after COVID-19 infection in young adults
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021



Late Breaking Abstract - Cytomegalovirus reactivation in COVID-19 patients with Acute Respiratory Distress Syndrome.
Source: Virtual Congress 2021 – Severe acute respiratory failure
Year: 2021



Respiratory Illness and Respiratory Syncytial Virus (RSV)-Related Hospitalization (RSVH In Infants with a Tracheostomy (Tr) in the CARESS Registry (2005-2016)
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018

Respiratory morbidity after hospitalisation with Respiratory Syncytial Virus and Rhinovirus infection.
Source: International Congress 2017 – Paediatric respiratory infections and immunity
Year: 2017



Respiratory Viral Trends in Adults
Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Year: 2020


Late Breaking Abstract - Clinical and epidemiological characteristics of Co-infection: respiratory tuberculosis and COVID-19.
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021


LATE-BREAKING ABSTRACT: IFN-gamma CA microsatellite Polymorphism is associated with the Susceptibility and Severity to Respiratory Syncytial Virus Infection
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014

Respiratory Physiological Sequelae following Coronavirus Infection: A Systematic Review
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021


Effect of 3 and 6%hypertonic saline in viral bronchiolitis: A RCT
Source: International Congress 2014 – Virus-triggered lower respiratory disease in children
Year: 2014


Late Breaking Abstract - Aggravated pathology in MRSA pneumonia secondary to Influenza A virus infection diverged from decreased expression of IL-1ß
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020


Late Breaking Abstract - WEAning From NonInvasive Ventilation – ‘WEANIV’ Study
Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation
Year: 2020



Rhinosinusitis in children: Seasonality and etiology
Source: International Congress 2014 – Respiratory infections in children
Year: 2014

Late Breaking Abstract - Wheeze phenotypes from very early infancy to 5 years: the CHILD Cohort Study.
Source: International Congress 2019 – Asthma epidemiology in the 21st century
Year: 2019

Identifying demographics and co-morbidities among hospitalised adults infected with acute Respiratory Syncytial Virus (RSV)
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017


Late Breaking Abstract - Characterization of hospitalized patients with Influenza: a retrospective study
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017

Respiratory viruses: international epidemiology - One Health Approach 
Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage
Year: 2017

Late Breaking Abstract - Global RSV-associated mortality in young children: a case series.
Source: International Congress 2017 – Late-breaking studies in asthma and COPD
Year: 2017



LATE-BREAKING ABSTRACT: Role of Interferon-á2b and Ribavirin in MERS-CoV Infection as Treatment and Prophylaxis
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014


Late Breaking Abstract - Development of an animal model for group 3 Pulmonary Hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018



Rapid spread of the novel respiratory syncytial virus A ON1 genotype, during the epidemic seasons 2011-2013
Source: International Congress 2014 – Virus-triggered lower respiratory disease in children
Year: 2014